List of Excipients in API halobetasol propionate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing halobetasol propionate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | CARBOMER COPOLYMER TYPE B | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | CARBOMER HOMOPOLYMER TYPE A | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | DIETHYL SEBACATE | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | EDETATE DISODIUM | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | LIGHT MINERAL OIL | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | METHYLPARABEN | |
| Bausch Health US LLC | BRYHALI | halobetasol propionate | 0187-0002 | PROPYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing halobetasol propionate
Detailed excipient profiles for halobetasol propionate
Excipient focus: ALCOHOL
halobetasol propionate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ALCOHOL
Excipient focus: ALLYL PENTAERYTHRITOL
halobetasol propionate drug variants containing ALLYL PENTAERYTHRITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teligent Pharma Inc | halobetasol propionate | 52565-073 |
| McKesson Corporation | halobetasol propionate | 63739-998 |
| Sola Pharmaceuticals | halobetasol propionate ointment | 70512-033 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ALLYL PENTAERYTHRITOL
Excipient focus: ALUMINUM STEARATE
halobetasol propionate drug variants containing ALUMINUM STEARATE
halobetasol propionate drug variants not containing ALUMINUM STEARATE
Excipient focus: BENZOIC ACID
halobetasol propionate drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing BENZOIC ACID
Excipient focus: BUTYLPARABEN
halobetasol propionate drug variants containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing BUTYLPARABEN
Excipient focus: CARBOMER COPOLYMER TYPE B
halobetasol propionate drug variants containing CARBOMER COPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CARBOMER COPOLYMER TYPE B
Excipient focus: CARBOMER HOMOPOLYMER TYPE A
halobetasol propionate drug variants containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CARBOMER HOMOPOLYMER TYPE A
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
halobetasol propionate drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Excipient focus: CETETH-20
halobetasol propionate drug variants containing CETETH-20
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CETETH-20
Excipient focus: CETOSTEARYL ALCOHOL
halobetasol propionate drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing CETOSTEARYL ALCOHOL
Excipient focus: CETYL ALCOHOL
halobetasol propionate drug variants containing CETYL ALCOHOL
halobetasol propionate drug variants not containing CETYL ALCOHOL
Excipient focus: DIAZOLIDINYL UREA
halobetasol propionate drug variants containing DIAZOLIDINYL UREA
halobetasol propionate drug variants not containing DIAZOLIDINYL UREA
Excipient focus: DIETHYL SEBACATE
halobetasol propionate drug variants containing DIETHYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing DIETHYL SEBACATE
Excipient focus: DIISOPROPYL ADIPATE
halobetasol propionate drug variants containing DIISOPROPYL ADIPATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing DIISOPROPYL ADIPATE
Excipient focus: EDETATE DISODIUM
halobetasol propionate drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing EDETATE DISODIUM
Excipient focus: GLYCERIN
halobetasol propionate drug variants containing GLYCERIN
halobetasol propionate drug variants not containing GLYCERIN
Excipient focus: ISOPROPYL ISOSTEARATE
halobetasol propionate drug variants containing ISOPROPYL ISOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Fougera Pharmaceuticals Inc | halobetasol propionate | 0168-0355 |
| Taro Pharmaceuticals USA Inc | halobetasol propionate | 51672-1321 |
| Bryant Ranch Prepack | halobetasol propionate | 63629-8735 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing ISOPROPYL ISOSTEARATE
Excipient focus: ISOPROPYL PALMITATE
halobetasol propionate drug variants containing ISOPROPYL PALMITATE
halobetasol propionate drug variants not containing ISOPROPYL PALMITATE
Excipient focus: LIGHT MINERAL OIL
halobetasol propionate drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing LIGHT MINERAL OIL
Excipient focus: METHYLCHLOROISOTHIAZOLINONE
halobetasol propionate drug variants containing METHYLCHLOROISOTHIAZOLINONE
halobetasol propionate drug variants not containing METHYLCHLOROISOTHIAZOLINONE
Excipient focus: METHYLISOTHIAZOLINONE
halobetasol propionate drug variants containing METHYLISOTHIAZOLINONE
halobetasol propionate drug variants not containing METHYLISOTHIAZOLINONE
Excipient focus: METHYLPARABEN
halobetasol propionate drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing METHYLPARABEN
Excipient focus: MONOSTEARYL CITRATE
halobetasol propionate drug variants containing MONOSTEARYL CITRATE
halobetasol propionate drug variants not containing MONOSTEARYL CITRATE
Excipient focus: OCTYLDODECANOL
halobetasol propionate drug variants containing OCTYLDODECANOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing OCTYLDODECANOL
Excipient focus: PENTAERYTHRITOL
halobetasol propionate drug variants containing PENTAERYTHRITOL
halobetasol propionate drug variants not containing PENTAERYTHRITOL
Excipient focus: PETROLATUM
halobetasol propionate drug variants containing PETROLATUM
halobetasol propionate drug variants not containing PETROLATUM
Excipient focus: POLAWAX POLYSORBATE
halobetasol propionate drug variants containing POLAWAX POLYSORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing POLAWAX POLYSORBATE
Excipient focus: POLOXAMER 407
halobetasol propionate drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing POLOXAMER 407
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
halobetasol propionate drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | halobetasol propionate | 51862-604 |
| Mayne Pharma | halobetasol propionate | 51862-606 |
| Mayne Pharma | halobetasol propionate | 68308-769 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
Excipient focus: PROPYLENE GLYCOL
halobetasol propionate drug variants containing PROPYLENE GLYCOL
halobetasol propionate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
halobetasol propionate drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM HYDROXIDE
halobetasol propionate drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing SODIUM HYDROXIDE
Excipient focus: SORBITAN MONOOLEATE
halobetasol propionate drug variants containing SORBITAN MONOOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing SORBITAN MONOOLEATE
Excipient focus: SORBITAN SESQUIOLEATE
halobetasol propionate drug variants containing SORBITAN SESQUIOLEATE
halobetasol propionate drug variants not containing SORBITAN SESQUIOLEATE
Excipient focus: SORBITOL
halobetasol propionate drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | halobetasol propionate | 0187-0002 |
| Bausch Health US LLC | halobetasol propionate and tazarotene | 0187-0653 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing SORBITOL
Excipient focus: STEARETH-21
halobetasol propionate drug variants containing STEARETH-21
halobetasol propionate drug variants not containing STEARETH-21
Excipient focus: STEARYL ALCOHOL
halobetasol propionate drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | halobetasol propionate | 10631-122 |
| >Company | >Ingredient | >NDC |
halobetasol propionate drug variants not containing STEARYL ALCOHOL
Excipient focus: WATER
halobetasol propionate drug variants containing WATER
halobetasol propionate drug variants not containing WATER
Excipient focus: WHITE WAX
halobetasol propionate drug variants containing WHITE WAX
halobetasol propionate drug variants not containing WHITE WAX
Excipient focus: YELLOW WAX
halobetasol propionate drug variants containing YELLOW WAX
halobetasol propionate drug variants not containing YELLOW WAX
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
